To conclude, the approach of making comparisons of differentially expressed gene sets in LEAD, AAA and CVD in relation to control group indicated that upregulation of GGT1 could be considered as a common feature of PBMCs from patients with these diseases (Figure 1C). This evidence concerns the gene GGT1 and triple-A syndrome.